PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
59.85
-1.24 (-2.03%)
Sep 15, 2025, 11:14 AM EDT - Market open
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$1,879,584
Profits / Employee
$670,046
Market Cap
4.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 939 | -116 | -11.00% |
| Dec 31, 2023 | 1,055 | -355 | -25.18% |
| Dec 31, 2022 | 1,410 | 233 | 19.80% |
| Dec 31, 2021 | 1,177 | 210 | 21.72% |
| Dec 31, 2020 | 967 | 206 | 27.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PTCT News
- 6 days ago - PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment - Benzinga
- 6 days ago - PTC Therapeutics, Inc. (PTCT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 days ago - PTC Therapeutics, Inc. (PTCT) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 7 days ago - PTC Therapeutics, Inc. (PTCT) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 25 days ago - PTC Therapeutics Stock Is Stuck In A Multi-Year Slump - Benzinga
- 25 days ago - PTC Therapeutics to Participate at Upcoming Investor Conferences - PRNewsWire
- 25 days ago - PTC Therapeutics: HD Treatment Advancement Continues With Q4 2025 Catalyst - Seeking Alpha
- 27 days ago - PTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns - Benzinga